ArticleNature communications2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
Douglas B Johnson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
399 papers cite itlatest 60 shown
this papertrialcites it